These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5764904)

  • 1. Exertion of delta-aminolevulinic acid in hereditary tyrosinemia.
    Gentz J; Johansson S; Lindblad B; Lindstedt S; Zetterström R
    Clin Chim Acta; 1969 Feb; 23(2):257-63. PubMed ID: 5764904
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity.
    Jagenburg R; Landblad B; De Maré JM; Rödjer S
    J Pediatr; 1972 Jun; 80(6):994-1004. PubMed ID: 5026040
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
    Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
    Deleña S; Brown H
    Metabolism; 1969 Nov; 18(11):901-5. PubMed ID: 5350555
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions.
    Bossenmaier I; Cardinal R
    Clin Chem; 1968 Jul; 14(7):610-4. PubMed ID: 5663456
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary tyrosinemia and abnormal pyrrole metabolism.
    Kang ES; Gerald PS
    J Pediatr; 1970 Sep; 77(3):397-406. PubMed ID: 5502089
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary coproporphyria. Photosensitivity, jaundice and neuropsychiatric manifestations associated with pregnancy.
    Hunter JA; Khan SA; Hope E; Beattie AD; Beveridge GW; Smith AW; Goldberg A
    Br J Dermatol; 1971 Apr; 84(4):301-10. PubMed ID: 5575195
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and treatment of the porphyrias.
    Goldberg A
    Proc R Soc Med; 1968 Feb; 61(2):193-6. PubMed ID: 5637835
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical studies in a patient with "tyrosinosis".
    Louis WJ; Pitt DD; Davies H
    Aust N Z J Med; 1974 Jun; 4(3):281-6. PubMed ID: 4531904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to delta-aminolevulinic acid and coproporphyrin determination. II].
    Weichardt H; Bardodĕj Z
    Zentralbl Arbeitsmed; 1969 Mar; 19(3):67-72. PubMed ID: 5772888
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption and excretion of mercury in man. 13. Effects of mercury exposure on urinary excretion of coproporphyrin and delta-aminolevulinic acid.
    Goldwater LJ; Joselow MM
    Arch Environ Health; 1967 Sep; 15(3):327-31. PubMed ID: 6035082
    [No Abstract]   [Full Text] [Related]  

  • 13. Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels.
    Strife CF; Zuroweste EL; Emmett EA; Finelli VN; Petering HG; Berry HK
    J Pediatr; 1977 Mar; 90(3):400-4. PubMed ID: 839332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrin metabolism during Versenate therapy in lead poisoning. Intoxication from an unusual source.
    Fromke VL; Lee MY; Watson CJ
    Ann Intern Med; 1969 May; 70(5):1007-12. PubMed ID: 4976891
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.
    Gentz J; Lindblad B; Lindstedt S; Zetterström R
    J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.
    Suzuki Y; Konda M; Imai I; Imamura H; Shimao S; Okaka T
    Int J Pediatr Nephrol; 1987; 8(3):171-6. PubMed ID: 3429140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional and preparative electrophoretic separation of some urinary porphyrins and porphyrin precursors.
    Fischl J; Eichhorn F; Ruttenberg A; Major C
    Clin Chem; 1970 Apr; 16(4):331-4. PubMed ID: 5442210
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of low lead exposure on the level of delta-aminolevulinic acid dehydratase activity.
    Milić S; Stanković M; Delić V
    Arh Hig Rada Toksikol; 1970; 21(3):241-6. PubMed ID: 5520411
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of exposure to lead on the degree of delta aminolevulinic dehydrase activity].
    De Bruin A
    Arh Hig Rada Toksikol; 1969; 20(4):487-94. PubMed ID: 5203124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.